https://www.selleckchem.com/pr....oducts/liproxstatin-
We propose consideration of an additional pathophysiological acute phenotype of respiratory failure, the mucus type (M-type). Patients with severe COVID-19 pneumonia who have persistent hypoxaemia despite the resolution of inflammatory parameters may respond to FFB with removal of mucus plugs. We propose consideration of an additional pathophysiological acute phenotype of respiratory failure, the mucus type (M-type).COVID-19 pneumonia, much like that of bacterial and viral community-acquired pneumonia before it, is accompanied by
Like
Comment
Share
